Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoloft in Young Children With Autism Spectrum Disorder
NCT02385799Phase 2Completed
- Start
- Apr 2015
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sertraline in Autism Spectrum Disorder (ASD). Primary endpoints: Mullen Scales of Early Learning - Expressive Language Raw Score at 6 months and Mullen Scales of Early Learning - Combined Age Equivalent Score at 6 months. Started Apr 2015; status: completed.
02
Drugs
sertraline
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT02385799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02385799.